This momentum favourite could stumble

Article Excerpt

IDEXX LABORATORIES INC. $122 (Nasdaq symbol IDXX; Aggressive Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 51.6 million; Market cap: $6.3 billion; Price-to-sales ratio: 4.8; No dividends paid; TSINetwork Rating: Average; www. idexx.com) earned $3.58 a share in 2013, up 12.6% from $3.18 in 2012. Sales rose 6.5%, to $1.4 billion from $1.3 billion. These gains are mainly because veterinarians are buying more of Idexx’s equipment for detecting diseases in pets. The company recently launched two new products that should increase this year’s sales by 7.5% to 8.5%. Its earnings should also rise to $3.85 a share. However, the stock has jumped 32% in the past year and now trades at a high 31.7 times the 2014 forecast. Idexx is still a hold. hold…